Pathophysiological changes of the neuromuscular transmission in the critically ill patient.
Khuenl-Brady
K S
KS
Department of Anaesthesiology and General Intensive Care, University of Innsbruck, Austria.
D003422:Critical Care; D016638:Critical Illness; D006801:Humans; D018908:Muscle Weakness / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D009468:Neuromuscular Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D009469:Neuromuscular Junction / Q000503:physiopathology*; D011950:Receptors, Cholinergic / Q000187:drug effects; D009435:Synaptic Transmission / Q000502:physiology*; D013577:Syndrome; D015854:Up-Regulation / Q000187:drug effects; D015300:Ventilator Weaning
D009466:Neuromuscular Blocking Agents; D011950:Receptors, Cholinergic